Source:  MORNING AG CLIPS, 7/9/19

A new Cornell University-led study describes the first successful rearing of engineered tobacco plants in order to produce medical and industrial proteins outdoors in the field, a necessity for economic viability, so they can be grown at large scales. The market for such biologically derived proteins is forecast to reach $300 billion in the near future. Industrial enzymes and other proteins are currently made in large, expensive fermenting reactors, but making them in plants grown outdoors could reduce production costs by three times.

For more of this story, click here.